The upregulation of plasma levels of VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ in Cancer TIF1-γ-DM patients could provide insight into the underlying mechanism of the pathogenesis of Cancer TIF1-γ-DM. This evidence concerns the gene CCL2 and dermatomyositis.